Menu
ÚHKT

Impaktované publikace

[1]

Mambet, C.; Babosova, O.; Defour, J.-P.; Leroy, E.; Necula, L.; Stanca, O.; Tatic, A.; Berbec, N.; Coriu, D.; Belickova, M.; et al.

Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

[rok vydání 2019, impact factor 16.562 ]

[2]

Prchal, J.T.; Prchal, J.F.; Belickova, M.; Chen, S.; Guan, Y.; Gartland, G.L.; Cooper, M.D.

Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism

[rok vydání 2006, impact factor 15.572]

[3]

Curik, N.; Burda, P.; Vargova, K.; Pospisil, V.; Belickova, M.; Vlckova, P.; Savvulidi, F.; Necas, E.; Hajkova, H.; Haskovec, C.; Cermak, J.; Krivjanska, M.; Trneny, M.; Laslo, P.; Jonasova, A.; Stopka, T.

5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity

[rok vydání 2012, impact factor 10.164 ]

[4]

Merkerova, M.D.; Remesova, H.; Krejcik, Z.; Loudova, N.; Hrustincova, A.; Szikszai, K.; Cermak, J.; Jonasova, A.; Belickova, M.

Relationship between altered miRNA expression and DNA methylation of the DLK1-DIO3 region in azacitidine-treated patients with myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes

[rok vydání 2018, impact factor 5.656 ]

[5]

Belickova, M.; Vesela, J.; Jonasova, A.; Pejsova, B.; Votavova, H.; Dostalova Merkerova, M.; Zemanova, Z.; Brezinova, J.; Mikulenkova, D.; Lauermannova, M.; Valka, J.; Michalova, K.; Neuwirtova, R.; Cermak, J.

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

[rok vydání 2016, impact factor 5.168 ]

[6]

Belickova, M.; Merkerova, M.D.; Stara, E.; Vesela, J.; Sponerova, D.; Mikulenkova, D.; Brdicka, R.; Neuwirtova, R.; Jonasova, A.; Cermak, J.

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

[rok vydání 2013, impact factor 4.933 ]

[7]

Merkerova, M.; Vasikova, A.; Belickova, M.; Bruchova, H.

MicroRNA expression profiles in umbilical cord blood cell lineages

[rok vydání 2009, impact factor 4.791]

[8]

Dostalova Merkerova, M.; Krejcik, Z.; Votavova, H.; Belickova, M.; Vasikova, A.; Cermak, J.

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

[rok vydání 2010, impact factor 4.400]

[9]

Hrustincova, A.; Krejcik, Z.; Kundrat, D.; Szikszai, K.; Belickova, M.; Pecherkova, P.; Klema, J.; Vesela, J.; Hruba, M.; Cermak, J.; Hrdinova, T.; Krijt, M.; Valka, J.; Jonasova, A.; Merkerova, M.D.

Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome

[rok vydání 2020, impact factor 4.366 ]

[10]

Votavova, H.; Grmanova, M.; Dostalova Merkerova, M.; Belickova, M.; Vasikova, A.; Neuwirtova, R.; Cermak, J.

Differential expression of microRNAs in CD34+ cells of 5q- syndrome

[rok vydání 2011, impact factor 3.990 ]

[11]

Dostalova Merkerova, M.; Bystricka, D.; Belickova, M.; Krejcik, Z.; Zemanova, Z.; Polak, J.; Hajkova, H.; Brezinova, J.; Michalova, K.; Cermak, J.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype

[rok vydání 2011, impact factor 3.546 ]

[12]

Svobodova, K.; Lhotska, H.; Hodanova, L.; Pavlistova, L.; Vesela, D.; Belickova, M.; Vesela, J.; Brezinova, J.; Sarova, I.; Izakova, S.; Lizcova, L.; Siskova, M.; Jonasova, A.; Cermak, J.; Michalova, K.; Zemanova, Z.

Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution

[rok vydání 2020, impact factor 3.444 ]

[13]

Cukrová, V.; Neuwirtová, R.; Doležalová, L.; Beličková, M.; Bartůňková, J.; Jonášová, A.; Čermák, J.; Homolková, H.; Malíková, I.

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

[rok vydání 2009, impact factor 3.106]

[14]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

[15]

Neupauerová, J.; Vraná, M.; Ratajová, E.; Nazarová, S.; Půbalová, Š.; Šálek, C.; Crivello, P.; Březinová, J.; Beličková, M.; Dyr, J.E.

The formation of a somatic mutation in the HLA-B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia

[rok vydání 2019, impact factor 2.785 ]

[16]

Svobodova, K.; Zemanova, Z.; Lhotska, H.; Podskalska, L.; Belickova, M.; Brezinova, J.; Sarova, I.; Izakova, S.; Lizcova, L.; Berkova, A.; Siskova, M.; Jonasova, A.; Cermak, J.; Michalova, K.

Copy number neutral loss of heterozygosity (CN-LOH) 17p and homozygous mutations of TP53 gene are associated with complex chromosomal aberrations (CCA) in newly diagnosed myelodysplastic syndromes (MDS)

[rok vydání 2015, impact factor 2.653 ]

[17]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Horakova, Z.; Campr, V.; Brezinova, J.; Zemanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome

[rok vydání 2017, impact factor 2.595 ]

[18]

Vasikova, A.; Belickova, M.; Budinska, E.; Cermak, J.

A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome

[rok vydání 2010, impact factor 2.555]

[19]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[20]

Neuwirtova, R.; Fuchs, O.; Holicka, M.; Vostry, M.; Kostecka, A.; Hajkova, H.; Jonasova, A.; Cermak, J.; Cmejla, R.; Pospisilova, D.; Belickova, M.; Siskova, M.; Hochova, I.; Vondrakova, J.; Sponerova, D.; Kadlckova, E.; Novakova, L.; Brezinova, J.; Michalova, K.

Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia

[rok vydání 2012, impact factor 2.396 ]

Neimpaktované publikace

[1]

Krejčová, H.; Neuwirtová, R.; Čermák, J.; Beličková, M.; Brdička, R.

Buněčná klonalita u myelodysplastického syndromu

[rok vydání 2006]